Influence of Pomegranate Juice Consumption on the Level of Antioxidants in Breast Milk (no)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Many medicinal effects of Pomegranate juices are already known. Mainly known for its anti-viral, anti-bacterial and anti-oxide tendency of pomegranate juice.
Many studies which have demonstrated antioxidant activity of pomegranate juice in the blood and blood cells were published.
In addition, published studies have demonstrated the anti-oxidant activity which inhibit the development of atherosclerosis and stroke, even in patients with diabetes, and its effect of decreasing systolic blood pressure in patients with systemic hypertension.
The purpose of the work is to examine the effect of drinking pomegranate juice on the level of anti-oxidants in human breast milk.
| Condition | Intervention |
|---|---|
|
Breast Milk |
Dietary Supplement: pomegranate juice |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Basic Science |
| Official Title: | Influence of Pomegranate Juice Consumption on the Level of Antioxidants in Breast Milk |
- anti oxidant level in human breast milk [ Time Frame: at least one year ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 40 |
| Study Start Date: | April 2013 |
| Estimated Primary Completion Date: | April 2015 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 2
label I- 200 cc pomegranate juice once daily for 6 weeks post partum. label II- control group, no placebo is givening.
|
Dietary Supplement: pomegranate juice |
Detailed Description:
the effect of pomegranate juice consumption on breast milk anti oxidants level.
Eligibility| Ages Eligible for Study: | 16 Years to 45 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- lactating woman
Exclusion Criteria:
- pomegranate allergy
- diabetes mellitus
- use of other Dietary Supplement
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Hillel Yaffe Medical Center |
| ClinicalTrials.gov Identifier: | NCT01800110 History of Changes |
| Other Study ID Numbers: | 0013-13 |
| Study First Received: | February 19, 2013 |
| Last Updated: | February 25, 2013 |
| Health Authority: | Israel: Ministry of Health |
Additional relevant MeSH terms:
|
Antioxidants Molecular Mechanisms of Pharmacological Action Pharmacologic Actions Protective Agents Physiological Effects of Drugs |
ClinicalTrials.gov processed this record on May 23, 2013